Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0630

-1.6%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: NTTG who wrote (11206)	4/27/2012 12:55:04 PM
From: TheMaster	1 Recommendation Read Replies (1) of 13111

Lies, Damn Lies, and statistics! LMAO. 20 in phase I, 80 phase II, and I think the compassionate use number is 160. For a total of 260 MM patients + Breast, + Liver, close to 300. What the heck, makes a better argument if you use your numbers! lol BTW The TGA said they would incorporate the compassionate use #'s into their criterion which is 250 patients dosed.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next